The privatisation offer for this small Catalist company could cause SGX some discomfort
The proposal to take Singapore Paincare private comes a mere five years after IPO, and highlights the local bourse’s chronic lack of liquidity
Add BT as a preferred source
[SINGAPORE] Amid a flurry of delistings from the Singapore Exchange (SGX), one more privatisation offer – especially that for a small Catalist player – should not make much of a difference.
After all, the local bourse looks on pace to hit at least 20 delistings or privatisation offers in the first half of this year.
Already, firms such as offshore oil-and-gas contractor Dyna-Mac and software company Silverlake Axis have delisted this year.
TRENDING NOW
Why China is tightening controls on overseas stock trading
Xi Jinping has just rewritten the rules of US-China rivalry
‘Even a CEO’s job can be replaced by AI’: DBS CEO Tan Su Shan bets big on agentic AI
‘Whole deck of cards just toppled’: FoodXervices’ Nichol Ng on how a 92-year-old family business unravelled – and what’s next
